Michael A Kaliner

Summary

Publications

  1. ncbi request reprint Omalizumab and the treatment of allergic rhinitis
    Michael A Kaliner
    Institute for Allergy and Asthma, 11160 Veirs Mill Road, Suite 414, Wheaton, MD 20902, USA
    Curr Allergy Asthma Rep 4:237-44. 2004
  2. ncbi request reprint Rhinitis and rhinologic headaches
    Mark D Scarupa
    Washington Hospital Center, Washington, DC, USA
    Allergy Asthma Proc 25:101-5. 2004
  3. pmc Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations
    Mark D Scarupa
    From the Institute for Asthma and Allergy, Bethesda, MD
    World Allergy Organ J 2:20-5. 2009
  4. doi request reprint Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis
    Michael A Kaliner
    Institute for Allergy and Asthma, Chevy Chase, Maryland 20817, USA
    Allergy Asthma Proc 30:255-62. 2009
  5. ncbi request reprint Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, Maryland 20815, USA
    Clin Ther 28:319-31. 2006
  6. doi request reprint Azelastine and olopatadine in the treatment of allergic rhinitis
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, Maryland 20815, USA
    Ann Allergy Asthma Immunol 103:373-80. 2009
  7. doi request reprint Comprehensive review of olopatadine: the molecule and its clinical entities
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, Maryland 20815, USA
    Allergy Asthma Proc 31:112-9. 2010
  8. ncbi request reprint Rhinosinusitis and the allergist
    Michael A Kaliner
    Institute for Asthma and Allergy, 11160 Veirs Mill Road, Suite 414, Wheaton, MD 20902, USA
    Curr Allergy Asthma Rep 5:421-4. 2005
  9. doi request reprint Nonallergic rhinopathy (formerly known as vasomotor rhinitis)
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, MD 20815, USA
    Immunol Allergy Clin North Am 31:441-55. 2011
  10. ncbi request reprint Asthma management: combining efficacy with safety
    Michael A Kaliner
    Institute for Asthma and Allergy, 11160 Veirs Mill Road, Suite 414, Wheaton, MD 20902, USA
    Curr Allergy Asthma Rep 5:91-2. 2005

Detail Information

Publications24

  1. ncbi request reprint Omalizumab and the treatment of allergic rhinitis
    Michael A Kaliner
    Institute for Allergy and Asthma, 11160 Veirs Mill Road, Suite 414, Wheaton, MD 20902, USA
    Curr Allergy Asthma Rep 4:237-44. 2004
    ....
  2. ncbi request reprint Rhinitis and rhinologic headaches
    Mark D Scarupa
    Washington Hospital Center, Washington, DC, USA
    Allergy Asthma Proc 25:101-5. 2004
    ..VMR was the most frequent cause of nasal inflammation, either alone or in combination with allergic rhinitis. Generally, headache symptoms improved with treatment of the underlying nasal inflammation in the majority of patients...
  3. pmc Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations
    Mark D Scarupa
    From the Institute for Asthma and Allergy, Bethesda, MD
    World Allergy Organ J 2:20-5. 2009
    ..Understanding and recognizing the presence of NAR in a patient is essential for the correct selection of medications and for successful treatment outcomes...
  4. doi request reprint Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis
    Michael A Kaliner
    Institute for Allergy and Asthma, Chevy Chase, Maryland 20817, USA
    Allergy Asthma Proc 30:255-62. 2009
    ..Olopatadine and fluticasone nasal sprays both reduced nasal and ocular SAR symptoms with no significant between-treatment differences except for a faster and greater onset of action with olopatadine...
  5. ncbi request reprint Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, Maryland 20815, USA
    Clin Ther 28:319-31. 2006
    ..Inhaled corticosteroids (ICSs) are the most potent anti-inflammatory choice for patients with asthma. Selecting the most appropriate ICS for a patient requires a thorough understanding of the pharmacologic properties of each drug...
  6. doi request reprint Azelastine and olopatadine in the treatment of allergic rhinitis
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, Maryland 20815, USA
    Ann Allergy Asthma Immunol 103:373-80. 2009
    ..To review the literature supporting current recommendations for nasal antihistamines as first-line therapy for allergic rhinitis...
  7. doi request reprint Comprehensive review of olopatadine: the molecule and its clinical entities
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, Maryland 20815, USA
    Allergy Asthma Proc 31:112-9. 2010
    ....
  8. ncbi request reprint Rhinosinusitis and the allergist
    Michael A Kaliner
    Institute for Asthma and Allergy, 11160 Veirs Mill Road, Suite 414, Wheaton, MD 20902, USA
    Curr Allergy Asthma Rep 5:421-4. 2005
  9. doi request reprint Nonallergic rhinopathy (formerly known as vasomotor rhinitis)
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, MD 20815, USA
    Immunol Allergy Clin North Am 31:441-55. 2011
    ..The clinical characteristics and differential diagnosis are provided in detail in this review, and the disease should now be characterized sufficiently for clinical studies...
  10. ncbi request reprint Asthma management: combining efficacy with safety
    Michael A Kaliner
    Institute for Asthma and Allergy, 11160 Veirs Mill Road, Suite 414, Wheaton, MD 20902, USA
    Curr Allergy Asthma Rep 5:91-2. 2005
  11. ncbi request reprint Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression
    Michael A Kaliner
    The Institute for Asthma and Allergy, Chevy Chase, Maryland 20815, USA
    Ann Allergy Asthma Immunol 90:629-34. 2003
    ..H1-receptor antagonists differ in their ability to produce peripheral H1-blockade. Suppression of histamine-induced flares and wheals is a useful objective test for measuring these differences...
  12. ncbi request reprint A novel and effective approach to treating rhinitis with nasal antihistamines
    Michael A Kaliner
    Institute for Asthma and Allergy, Wheaton, Maryland 20902, USA
    Ann Allergy Asthma Immunol 99:383-90; quiz 391-2, 418. 2007
    ..Study Selection: All key relevant articles were reviewed and the most relevant selected for inclusion in this review...
  13. ncbi request reprint Adjuvant therapies in the treatment of acute and chronic rhinosinusitis
    Mark D Scarupa
    Institute for Asthma and Allergy, Johns Hopkins Asthma and Allergy Center, Chevy Chase, Maryland, USA
    Clin Allergy Immunol 20:251-62. 2007
  14. ncbi request reprint The treatment of vasomotor nonallergic rhinitis
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase, Maryland, USA
    Clin Allergy Immunol 19:351-62. 2007
  15. doi request reprint The efficacy of intranasal antihistamines in the treatment of allergic rhinitis
    Michael A Kaliner
    Institute for Asthma and Allergy, Chevy Chase and Wheaton, Maryland, and George Washington University School of Medicine, Washington, DC, USA
    Ann Allergy Asthma Immunol 106:S6-S11. 2011
    ....
  16. ncbi request reprint H1-antihistamines in the elderly
    Michael A Kaliner
    Institute for Allergy and Asthma, Wheaton, Maryland, USA
    Clin Allergy Immunol 17:465-81. 2002
    ..Adjustments in dosages are necessary when some agents are used in patients with renal and/or hepatic disease; however, overall, the use of the newer nonsedating antihistamines is safe, effective, and gratifying in the elderly...
  17. ncbi request reprint Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis
    Phil Lieberman
    Allergy and Asthma Care, Germantown, TN, USA
    Curr Med Res Opin 21:611-8. 2005
    ....
  18. ncbi request reprint Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma
    Brian J Lipworth
    Allergy Research Group, Department of Medicine and Therapeutics, University of Dundee, Dundee, Scotland
    Ann Allergy Asthma Immunol 94:465-72. 2005
    ..Ciclesonide (hydrofluoroalkane propellant) is a novel inhaled corticosteroid with few, if any, clinical adverse events...
  19. ncbi request reprint Cromolyn sodium: fitting an old friend into current asthma treatment
    William Storms
    University of Colorado Health Sciences Center, Colorado Springs, Colorado 80907, USA
    J Asthma 42:79-89. 2005
    ..This review reexamines the role of cromolyn sodium (now available as an HFA aerosol) in the treatment of asthma...
  20. ncbi request reprint The diagnosis and management of sinusitis: a practice parameter update
    Raymond G Slavin
    J Allergy Clin Immunol 116:S13-47. 2005
  21. ncbi request reprint Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council
    John O Warner
    Southampton General Hospital Centre, Southampton, UK
    Int Arch Allergy Immunol 139:166-74. 2006
    ..Nine countries only reported that children with allergic diseases would be seen by a pediatrician with appropriate training. The survey results highlight a pressing need for the development of allergy services worldwide...